Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Total Current Liabilities (2018 - 2025)

Historic Total Current Liabilities for Revolution Medicines (RVMD) over the last 8 years, with Q3 2025 value amounting to $245.6 million.

  • Revolution Medicines' Total Current Liabilities rose 12155.45% to $245.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $245.6 million, marking a year-over-year increase of 12155.45%. This contributed to the annual value of $163.9 million for FY2024, which is 1394.71% up from last year.
  • As of Q3 2025, Revolution Medicines' Total Current Liabilities stood at $245.6 million, which was up 12155.45% from $184.5 million recorded in Q2 2025.
  • In the past 5 years, Revolution Medicines' Total Current Liabilities ranged from a high of $245.6 million in Q3 2025 and a low of $43.8 million during Q1 2021
  • Its 5-year average for Total Current Liabilities is $99.1 million, with a median of $78.1 million in 2023.
  • The largest annual percentage gain for Revolution Medicines' Total Current Liabilities in the last 5 years was 13207.76% (2023), contrasted with its biggest fall of 491.32% (2023).
  • Quarter analysis of 5 years shows Revolution Medicines' Total Current Liabilities stood at $60.4 million in 2021, then rose by 2.71% to $62.0 million in 2022, then skyrocketed by 132.08% to $143.9 million in 2023, then grew by 13.95% to $163.9 million in 2024, then skyrocketed by 49.85% to $245.6 million in 2025.
  • Its Total Current Liabilities stands at $245.6 million for Q3 2025, versus $184.5 million for Q2 2025 and $158.6 million for Q1 2025.